Overview

This trial is active, not recruiting.

Condition gastrointestinal cancer
Sponsor Haematology-Oncology
Start date September 2012
End date December 2014
Trial identifier NCT00716209, NUSIRB 04-116

Summary

The proposal seeks to establish:

- A comprehensive compilation (database) of clinical information comprising clinical, histopathological, treatment and follow-up characteristics of past and future gastrointestinal cancer (GIC) cases in Singapore that can be shared by investigators. The characteristics will include clinical (eg age, sex, stage), histopathological (eg. grade, type), treatment (eg. treatment status, regimens) and outcome data (eg. survival, toxicity) from medical records.

- A collection (bank) of corresponding frozen and fixed tissue, blood and processed samples (enriched blood mononuclear cells, protein, RNA, DNA, tissue arrays) in Singapore that can be shared by the investigators.

- A gastrointestinal cancer co-operative group (GCCG) of clinicians and scientists researching prognostic and predictive markers in GIC, which will benefit from the multi-disciplinary knowledge, information and samples of its members.

- To characterise genetic polymorphisms related to Gastrointestinal cancer chemotherapy treatment in controls (healthy volunteers)

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective
Arm
Patients with cancers of the gastrointestinal tract (eg. colorectal, gastric, pancreatic, esophageal)

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Patients with cancers of the gastrointestinal tract (eg. colorectal, gastric, pancreatic, esophageal) Exclusion Criteria: - None

Additional Information

Official title Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
Principal investigator Ross Andrew Soo, MBBS
Trial information was received from ClinicalTrials.gov and was last updated in March 2014.
Information provided to ClinicalTrials.gov by National University Hospital, Singapore.